We report on the clinical status of 5 patients with Parkinson's disease (PD) 
tients, 2 years after fetal ventral mesencephalon (VM)-and fetal adrenal (A)-to-CN homotransplantation. Current clinical evaluation of 4 of the AM grafted patients revealed sustained bilateral amelioration of their PD signs, most notably of rigidity, postural imbalance and gait distur- bances, resulting in a substantial improvement in their quality of life. The disease-related dystonia of one of them disappeared only 2 years after surgery. The levodopa requirements of 2 of these patients and the antichoHnergic therapy of another have been reduced. In agreement with the satisfactory clinical evaluation of these 4 patients, their neuropsychological and electrophysiological improvements, initially registered 3 months after surgery, have been maintained for 3 years. After 1 year of significant recovery, the 5th patient of this group has almost returned to her preoperative state.
The 2 homotransplanted patients also showed sustained bilateral improvement of their PD signs. Two years after surgery, the most improved signs of the fetal VM case were rigidity, bradykinesia, postural imbalance, gait disturbances and facial expression. The fetal A case has only shown amdioration of rigidity and bradykinesia. Neither The current postoperative levodopa therapy of the autotransplanted patients is indicated in Table 2 . Of the 3 autotransplanted patients who were taking levodopa before surgery, the current postoperative dose of one of them (NAG) has been significantly reduced, and that of another '-LUME 2, NO. [3] [4] 1991 
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The postoperative UPRS courses in "on" and "off' of the 2 homotransplanted parkinsonians are shown in Fig. 4 assume their place as implantation alternatives for each individual patient.
